More On Health and Politics: The Peculiar Timing of Republican Health Policy Plans April 9, 2024 From Drew Altman In this column, KFF President and CEO Drew Altman examines the conservative Republican Study Committee’s sweeping proposals to remake Medicare, Medicaid and the Affordable Care Act and their potential to make waves in this year’s elections. Whether former President Trump ignores, embraces, or repudiates their ideas will be key.
Experience of the Five Largest Publicly Traded Companies Operating Medicaid Managed Care Plans During Unwinding April 3, 2024 Issue Brief This brief takes a closer look at the five largest publicly traded companies (also referred to as “parent” firms) operating Medicaid MCOs, which account for half of Medicaid MCO enrollment nationally. This analysis presents the latest enrollment and financial data (through the end of 2023) as well as key takeaways from the firms’ unwinding experience.
Variability in Payment Rates for Abortion Services Under Medicaid March 28, 2024 Issue Brief This brief looks at Medicaid reimbursement rates for abortion services across states, including D&C and D&E procedures, and medication abortion. There is tremendous variability in how much states reimburse for abortion services.
SUD Treatment in Medicaid: Variation by Service Type, Demographics, States and Spending March 28, 2024 Issue Brief Substance use disorders contribute to a growing number of deaths, yet they often go undiagnosed and untreated. While nearly three-quarters of Medicaid enrollees with a diagnosed substance use disorder utilized some type of treatment service in 2020, medication treatment rates varied widely, being much lower for alcohol use disorder than opioid use disorder, and lower among Black enrollees and youth compared to their counterparts. Treatment rates varied considerably across states and average Medicaid spending for people with a diagnosed substance use disorder is over twice as high compared to those without a substance use disorder.
Is Medicaid Too Big to… Block Grant? March 26, 2024 From Drew Altman In his latest column, KFF President and CEO Drew Altman examines how the politics around the Medicaid program have changed as it has grown much larger and more popular, making it even tougher to block grant the program to cut federal Medicaid spending and hand it off to the states.
The Impact of the Pandemic on Well-Child Visits for Children Enrolled in Medicaid and CHIP March 18, 2024 Issue Brief This issue brief examines well-child visit rates overall and for selected characteristics before and after the pandemic began and discusses recent state and federal policy changes that could impact children’s preventive care. More than half of children under age 21 enrolled in Medicaid or CHIP received a well-child visit in 2019, but the share fell to 48% in 2020, the start of the COVID-19 pandemic.
A Closer Look at the Remaining Uninsured Population Eligible for Medicaid and CHIP March 15, 2024 Issue Brief This issue brief examines the characteristics of the remaining uninsured population who are eligible for Medicaid or CHIP using 2022 national survey data. Despite improvements in coverage, 25.6 million nonelderly people remained uninsured in 2022.
A Closer Look at Medicaid Expansion Efforts in Mississippi March 12, 2024 Blog This policy watch examines Mississippi’s recent Medicaid expansion activity, what expansion could mean for residents and the economy, and key developments to watch.
Section 1115 Medicaid Waiver Watch: A Closer Look at Recent Approvals to Address Health-Related Social Needs (HRSN) March 4, 2024 Issue Brief This issue brief provides an overview of how Section 1115 waivers have been used to address the health-related social needs of enrollees, including a summary of recent approvals for eight states.